What are the three integral components of conventional TACE?

Foundations of Transarterial Chemoembolization (TACE) with Dr. Michael Soulen

Lesson 1

How did you establish your IR clinic?

Lesson 2

How was TACE developed and how has it evolved over time?

Lesson 3

What are the three integral components of conventional TACE?

Lesson 4

How do you properly mix the drug solution and Lipiodol for administration?

Lesson 5

How do different types and sizes of embolic particles impact embolization procedures and outcomes?

Lesson 6

How are common side effects like taste changes and pain managed in TACE procedures?

Lesson 7

How do the procedural protocols for patients with neuroendocrine tumors differ?

Lesson 8

What are the key clinical trials that have had the most impact on modern IO practice?

Lesson 9

What is the current role of chemoembolization compared to Y-90 in the treatment of HCC?

Immunotherapy in HCC: Evolving Treatment Paradigms with Dr. Tyler Sandow, Dr. Edward Kim & Dr. Terence Gade

Lesson 10

Can you give a backround on systemic therapy for HCC?

Lesson 11

Can you go into the basic science of how immunotherapy works?

Lesson 12

How do HCC referrals come into your practice?

Lesson 13

Tell us about how your tumor board works?

Lesson 14

Tell us about the trials that have put us where we are in the BCLC algorithm?

Lesson 15

Tell me why you would choose one local regional therapy over an other?

Lesson 16

Why would you choose one local regional therapy over another and what would you choose?

Lesson 17

Is combination therapy for HCC safe for patients?

Lesson 18

Do you favor Conventional TACE or DEB TACE, and how do you do it?

Lesson 19

How do you treat multifocal HCC?

Lesson 20

When do you re-image patients after treatment?

Radiation Segmentectomy for HCC with Dr. Juan Gimenez & Dr. Tyler Sandow

Lesson 21

Describe your practice and the importance of the teamwork required to maintain a busy tertiary referral center

Lesson 22

Can you describe the evolution of treatment for HCC at Ochsner?

Lesson 23

Tell us about your referral patterns for these patients

Lesson 24

Take us through the patient preparation process for treatment of HCC

Lesson 25

What are some strategies for improving throughput and prioritizing patients via multidisciplinary care

Lesson 26

Tell us about patient selection and your treatment algorithm for HCC

Lesson 27

What is your approach to lobar treatment, and when do you target specific areas for treatment?

Lesson 28

Tell us about how Y-90 works and the concept of the sphere conundrum

Lesson 29

Can you talk about how the sphere conundrum directs your approach?

Lesson 30

How do you consider the margins around the tumor when treating with Y-90?

Lesson 31

Do you have helpful dosimetry software and when did you start using it?

Lesson 32

Talk about how you-re selecting your dose

Lesson 33

What do you do when you have a centrally located big tumor with multiple feeders?

Lesson 34

With underlying liver disease, do you have a cutoff for how much volume you want to preserve?

Lesson 35

Are you publishing any of your findings?

Lesson 36

Can you talk about combination therapies with systemic?

TREATLIVE Y-90 for HCC case at Mt. Sinai

Lesson 37

TREAT Y-90 HCC Ed Kim